Clinical Trial for Integrated Care to Help At Risk Teen (iCHART) Intervention

Part of paid clinical trials in Gibbsboro, New Jersey.

Sponsor
University of Pittsburgh
Study ID
NCT05748730
Status
Recruiting

Conditions

  • Adolescent Behavior
  • Suicide and Depression

Eligibility Criteria

Sex
ALL
Age
12 Years - 18 Years
Healthy Volunteers
Not accepted

Interventions

  • iCHART — BEHAVIORAL
    The Safety Planning App will guide primary care providers or mental health clinicians in the use of an emotion regulation and safety planning app (BRITE) to be loaded on the phone of depressed and suicidal adolescents in order to improve depression and reduce the likelihood of a suicide attempt. The Mental Health Screener is a decision support tool to guide the primary care provider to make a referral that reflects patient clinical needs and patient and parental treatment preferences and perceived barriers to treatment. The Text Messages is a personalized text messaging intervention for patients and parents that targets engagement with the safety plan to increase the likelihood that a depressed or suicidal patient will maintain or initiate recommended services. Participants will receive usual care at their pediatric primary care practice following screening including information, psychoeducation, and referral to a mental health treatment provider.
  • Treatment As Usual — BEHAVIORAL
    Participants in this group will receive usual care from their primary care provider or mental health care provider which may include development of a paper safety plan.

Study Details

This protocol will test the effectiveness of an intervention, iCHART (integrated Care to Help At-Risk Teens) and facilitate recruitment for other studies in the larger ETUDES Center grant, which are focused on treatment development for target risk factors for suicidal behavior, specifically, sleep, anhedonia, and stress related to cybervictimization. This study will recruit 900 adolescents which will be enrolled in a randomized controlled trial to test iCHART and will be randomized to iCHART or treatment as usual (TAU). Based on previous work, the investigators hypothesize that iCHART, compared to TAU, will decrease suicidal-related events by 50%, and the effects will be mediated by increases in referrals, treatment engagement, and safety planning. The investigators will use implementation science methods to assess contextual factors (i.e., barriers and facilitators) and implementation outcomes specifically, acceptability, feasibility, appropriateness, and cost for our predictive algorithm and iCHART to inform future implementation efforts and promote health equity.

Key Dates

Start date
Jan 26, 2023
Status verified
Jun 2026
Primary completion
Apr 30, 2027
Completion
Apr 30, 2027

Study Design

Enrollment
900 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH

Arms

  • Experimental: iCHART
    iCHART is an intervention that includes 3 components previously studied in within the ETUDES Center including a: 1. Safety Planning App for suicidal youth which enables a primary care provider to streamline the gold standard of care for those with current suicidality symptoms through an app (instead of a paper based version); 2. Mental Health Screener questionnaire that gathers additional mental health symptoms, treatment preferences, and family's readiness for treatment engagement to help primary care provider make a personalized, tailored treatment plan a suicidal youth is more likely to adhere to; 3. Text Messages which aims to provide texts for 2-3 weeks to motivate you to engage with the safety plan and recommended treatment following the patient visit. Participants will receive usual care at their pediatric primary care practice following screening including information, psychoeducation, and referral to a mental health treatment provider.
  • Active Comparator: Treatment As Usual (TAU)
    Participants in this group will receive usual care from their primary care provider or mental health care provider which may include development of a paper safety plan.

Primary Outcome Measure

Depression Severity [ Time Frame: Baseline ]

Central Contacts

Locations (13)

FacilityCityStateZIPSite coordinators
GibbsboroGibbsboroNew Jersey08026
Jeffrey Fendrick, MD
856-783-2802
Conemaugh Memorial Medical Center-Family MedicineJohnstownPennsylvania15905
Jeannie Spencer, MD
(814) 534-9106
CHOP Primary Care, CHOP CampusPhiladelphiaPennsylvania19104
Kathleen Zsolway, DO
215-590-2178
CHOP Primary Care, Cobbs CreekPhiladelphiaPennsylvania19139
Andrea McGeary, MD
215-476-2223
KarabotsPhiladelphiaPennsylvania19139
Kari Draper, MD
267-425-9800
RoxboroughPhiladelphiaPennsylvania19128
Maria Dugan, MD
2154833444
Children's Community Pediatrics (CCP) of Children's Hospital of Pittsburgh UPMCPittsburghPennsylvania15213
Chris Cepullio, BSN, RN, CPPS
724-933-1100
Kids Plus Pediatrics (KPP)PittsburghPennsylvania15217
Lisa Zur, MPH
412-521-6511
UPMC Center for Adolescent and Young Adult HealthPittsburghPennsylvania15213
Ana Radovic, MD
412-692-6677
UPMC Family MedicinePittsburghPennsylvania15213
Tracey Conti, MD
412-383-2378
Jonathan Raviotta, MD
412-383-2378
Berks Community Health CenterReadingPennsylvania19604
Helen Wooten
(610) 988-4838
SpringfieldSpringfieldPennsylvania19064
Jonathan Lee, MD
610-604-0888
CHOP Primary Care, West ChesterWest ChesterPennsylvania19380
Wendy Wallace, DO
610-436-8611

Find similar trials in Gibbsboro, NJ

Related Studies